Affiliation:
1. Department of Thoracic Surgery University Hospital Zurich Zurich Switzerland
Abstract
AbstractExtended lung resections for T3–T4 non‐small‐cell lung cancer remain challenging. Multimodal management is mandatory in multidisciplinary tumor boards, and here the determination of resectability is key. Long‐term oncologic efficacy depends mostly on complete resection (R0) and the extent of N2 disease. The development of novel innovative treatments (targeted therapy and immune checkpoint inhibitors) sets interesting perspectives to reinforce current therapeutic options in the induction and adjuvant setting.
Subject
Oncology,General Medicine,Surgery
Reference84 articles.
1. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
2. The Eighth Edition Lung Cancer Stage Classification
3. Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline
4. NCC Network. NCCN clinical practice guidelines in oncology: non‐small cell lung cancer 2022. Accessed November 13th 2022. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
5. NCC Network. NCCN clinical practice guidelines in oncology: non‐small cell lung cancer 2021. August 18 2021. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献